Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

56.81 +0.56 (+1.00%)

Streaming Delayed Price Updated: 9:44 AM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

34 35 Next >

7 Biotech Stocks to Put on Your Breakthrough Radar ↗

May 27, 2024

Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance.

Via InvestorPlace

3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow ↗

May 26, 2024

There are a handful of different factors that could buoy its stock.

Via The Motley Fool

The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now ↗

May 23, 2024

With interest cuts on the horizon, it's a prime time to consider these high-risk-high-reward biotech stocks to buy.

Via InvestorPlace

7 Must-Buy Stocks if You Only Have $1,000 to Spend: May Edition ↗

May 22, 2024

With a modest $1,000 investment, these stocks offer the potential for market-beating gains through solid fundamentals and growth prospects.

Via InvestorPlace

Is CRISPR Therapeutics a Millionaire Maker? ↗

May 22, 2024

The stars are aligning for it to be a leader for years to come.

Via The Motley Fool

Is CRISPR Therapeutics Stock a Buy? ↗

May 17, 2024

The gene-editing therapy specialist is rising in prominence.

Via The Motley Fool

Bull Market Buys: 2 Growth Stocks to Own for the Long Run ↗

May 22, 2024

These biotech stocks have just launched their first products.

Via The Motley Fool

Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗

May 17, 2024

With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.

Via InvestorPlace

7 No-Brainer Stocks to Buy and Hold for the Next 20 Years: May 2024 ↗

May 16, 2024

Here are seven stocks to buy and hold that are poised for long-term growth over the next 20 years and can future-proof your portfolio.

Via InvestorPlace

Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So. ↗

May 15, 2024

How much would you pay for a stock that might earn $25 a year in six years?

Via The Motley Fool

2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential ↗

May 14, 2024

These healthcare stocks offer completely different approaches to long-term investment gains.

Via The Motley Fool

The 3 Best Cathie Wood Stocks to Buy in May 2024 ↗

May 13, 2024

Cathie Wood takes a very risky approach to investing, but she has plenty of great picks. Here are some of the best Cathie Wood stocks to buy.

Via InvestorPlace

The 3 Most Undervalued Biotech Stocks to Buy in May 2024 ↗

May 11, 2024

Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns.

Via InvestorPlace

Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life ↗

May 10, 2024

Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today.

Via InvestorPlace

Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine ↗

May 09, 2024

These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot.

Via InvestorPlace

CRSP Stock Earnings: CRISPR Therapeutics Misses EPS, Misses Revenue for Q1 2024 ↗

May 08, 2024

CRSP stock results show that CRISPR Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

3 Biotech Stocks With the Potential to Make You an Overnight Millionaire ↗

May 04, 2024

Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments.

Via InvestorPlace

Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar ↗

May 03, 2024

The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines.

Via InvestorPlace

3 Growth Stocks You’ll Kick Yourself for Not Buying Today ↗

May 03, 2024

Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns.

Via InvestorPlace

3 Biotech Stocks to Buy and Hold Through 2030 and Beyond ↗

May 02, 2024

It pays to develop novel medicines for life-threatening illnesses.

Via The Motley Fool

3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire ↗

May 02, 2024

Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion.

Via InvestorPlace

Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge ↗

May 01, 2024

A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount.

Via InvestorPlace

Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

April 24, 2024

Good news could be just around the corner for two drugmakers not named Novo Nordisk.

Via The Motley Fool

Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy? ↗

April 23, 2024

Vertex is broadening its portfolio.

Via The Motley Fool

3 Magnificent Stocks That Could Double or More by 2030 ↗

April 13, 2024

There's no guarantee these stocks will double by 2030, but their growth prospects look great.

Via The Motley Fool

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024 ↗

April 11, 2024

In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.

Via InvestorPlace

Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics ↗

April 09, 2024

These rising drugmakers have serious arguments in their favor.

Via The Motley Fool

Bull Market and Beyond: 3 Stocks Just Waiting to Soar ↗

April 09, 2024

These stocks, a bargain today, are players to hold on to for the long term.

Via The Motley Fool

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics ↗

April 05, 2024

These companies are in the early days of their growth stories.

Via The Motley Fool

3 Unstoppable Stocks to Buy Hand Over Fist in April ↗

March 30, 2024

These stocks have exceptionally bright prospects.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.